New hope for kidney cancer patiens with 'breakthrough' drugs combination

Scientists have found combining two powerful agents could clear kidney cancer tumours.

A ‘breakthrough’ combination of drugs, nivolumab and ipilimumab, is set to give hope to thousands of patients with kidney cancer. They have discovered that combining two powerful agents has the potential to clear tumours from patients. A small-scale trial found that giving the combination together cleared tumours from up to a tenth of patients whose kidney cancer had spread to other organs, after a four-month treatment regime.

The combination also shrank tumours in 40 per cent of these patients – a higher response rate than achieved with drugs currently available on the NHS.

From The Mail online. To read the full story CLICK HERE